MedTrace Logo

Evaluation of Immunological Disorders of T Lymphocytes and Endocrinological Disorders as Pathogen Factors in Patients With Metaplasia of Urinary Bladder

NCT02092558 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2

Last updated 2014-03-20

No results posted yet for this study

Summary

Background: Squamous metaplasia refers to the pathological transformation of the urothelium leading to non-keratinised stratified squamous metaplasia (N-KSM).

Objective: To present the investigators experiences in the diagnosis and treatment of N-KSM of the urinary bladder in children.

Conditions

  • The Follow-up Duration Was 1-8 Years.
  • The Main Reasons Behind Visiting the Hospital Were Recurrent Urinary Tract Infection,
  • Urinary Urgencies, Pollakiuria, Difficulty in Initiating Micturition, Pain in Hypogastrium,
  • Night Wetting and Day Wetting, Menstruation's Disorders, Urolithiasis, Defects of Urinary
  • System and Hematuria.

Interventions

DRUG

Second-generation cephalosporin, nitrofurantoin, 1% aminoglycoside solution

DRUG

cephalosporin with chemotherapeutics

Second-generation cephalosporin was prescribed for 10 days, and then treatment crossover with chemotherapeutics in therapeutic dose (change in every week) during 3 months

Sponsors & Collaborators

  • Children's Hospital, Dziekanów Leśny, Poland

    lead OTHER

Eligibility

Min Age
5 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-01-31
Primary Completion
2009-01-31
Completion
2013-12-31

Countries

  • Poland

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02092558 on ClinicalTrials.gov